Orthocell’s Remplir Used in 23 Combat Nerve Repairs for Ukrainian Soldiers
Orthocell’s Remplir device has been used in 23 nerve repair surgeries on Ukrainian soldiers injured in combat, following a humanitarian delivery in April 2025. The collagen-based implant’s room-temperature storage, three-year shelf life and successful remote surgeon training demonstrate its clinical utility and transportability in frontline trauma care.
1. Humanitarian Delivery and Field Use
Orthocell delivered shipments of its Remplir collagen-based nerve repair device to Ukraine in April 2025, and local surgeons have since applied it in 23 procedures on injured soldiers.
2. Clinical Performance and Feedback
Surgeons conducting both primary and secondary nerve repairs praised the device’s handling and clinical performance in reconstructing severed nerves and preserving patient function.
3. Portability, Storage and Remote Training
The implant’s room-temperature storage, three-year shelf life and remote video training program enabled surgeons to adopt Remplir despite logistical constraints in active conflict zones.
4. Pathway to Defence Sector Adoption
Orthocell plans to monitor patient outcomes and use real-world data to support discussions with global defence organisations for broader military and trauma care deployments.